Email this article IMMUNOLOGICAL ASPECTS OF OBESITY
- Authors: Gusova Z.R.1, Dzantieva E.O.1, Khripun I.A.1
-
Affiliations:
- Rostov State Medical University, Rostov-on-Don
- Issue: 2015: Supplement 1
- Pages: 30-35
- Section: THE PROBLEM OF OBESITY
- URL: https://almclinmed.ru/jour/article/view/60
- DOI: https://doi.org/10.18786/2072-0505-2015-1-1-3-10
- ID: 60
Cite item
Full Text
Abstract
Background: At present, convincing data on the role of immune system in pathophysiology of obesity are lacking, which makes it necessary to investigate this issue. Aim: To assess metabolic status and characteristics of immune system in patients with overweight and morbid obesity.
Materials and methods: One hundred and ninety two patients with overweight and advanced obesity (mean body mass index (BMI) 36.8 ± 7.3 kg/m. aged from 19 to 55 years) were recruited in to the study. Depending on the grade of obesity, the patients were divided into two groups. Group 1 included 84 overweight patients (BMI 27.65 ± 0.17 kg/m.), group 2 included 88 patients with obesity grade III (BMI 44.03 ± 0.44 kg/m.). The groups were comparable as to their age and gender. The control group comprised 20 otherwise healthy subjects with normal body weight. Assessments included parameters of carbohydrate and lipid metabolism, hemodynamic parameters, immune status including cytokine profile.
Results: In patients of both groups abnormalities in carbohydrate and lipid metabolism were found, together with changes of hemodynamic parameters which were more advanced with higher degree of obesity. These parameters demonstrated that obesity promotes manifestation of metabolic syndrome. There was remarkable imbalance in pro-inflammatory cytokines. Patients with obesity grade III had a statistically significant (р = 0.05) increase in their serum levels of tumor necrosis factor-α (6.32 ± 0.49 vs 2.14 ± 0.25), interleukin (IL)-4 (7.56 ± 0.44 vs 1.44 ± 0.10), IL-6 (5.39 ± 0.89 vs 2.02 ± 0.16), IL-17 (2.74 ± 0.29 vs 0.59 ± 0.20) both in basal and stimulated conditions, compared to those in patients with overweight and control patients.
Conclusion: The study showed that imbalance in immune system increases with an increase of obesity grade. This imbalance implies lymphocyte maturation and differentiation, higher cytotoxicity of immunocompetent cells, over expression of receptors both to proand anti-inflammatory cytokines, apoptosis activation, abnormalities in inter-cellular cooperation and disorders of phagocytic adaptation reserve.
About the authors
Z. R. Gusova
Rostov State Medical University, Rostov-on-Don
Author for correspondence.
Email: docgzr@yandex.ru
Gusova Zalina Ruslanovna – PhD, Associate Professor, Department of Endocrinology, Faculty of Advanced Training and Professional Retraining of Specialists
* 111–11 Metallurgicheskaya ul., Rostov-on-Don, 344029, Russian Federation. Tel.: +7 (863) 22 82 69. E-mail: docgzr@yandex.ru
Russian FederationE. O. Dzantieva
Rostov State Medical University, Rostov-on-Don
Email: docgzr@yandex.ru
Dzantieva Elizaveta Olegovna – Postgraduate Student, Department of Endocrinology, Faculty of Advanced Training and Professional Retraining of Specialists
Russian FederationI. A. Khripun
Rostov State Medical University, Rostov-on-Don
Email: docgzr@yandex.ru
Khripun Irina Alekseevna – PhD, Assistant Professor, Department of Endocrinology, Faculty of Advanced Training and Professional Retraining of Specialists
Russian FederationReferences
- Аметов АС. Избранные лекции по эндокринологии. М.: МИА; 2012. 543 с. (Ametov AS. Selected lectures in endocrinology. Moscow: MIA; 2012. 543 p. Russian).
- Bray G. A guide to obesity and the metabolic syndrome. Origins and treatment. New York: CRC Press: Taylor and Francis Group; 2011. 375 p.
- Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol. 2008;23(6):591–8.
- Бубнова МГ. Ожирение: причины и механизмы нарастания массы тела, подходы к коррекции. Consilium Medicum. 2005;7(5): 409–15. (Bubnova MG. [Obesity: Causes and mechanisms of increase in body weight, ways of its correction]. Consilium Medicum. 2005;7(5):409–15. Russian).
- Гинзбург ММ, Крюков НН. Ожирение. Влияние на развитие метаболического синдрома. Профилактика и лечение. М.: Медпрактика; 2002. 182 с. (Ginzburg MM, Kryukov NN. Obesity. Effect on the development of metabolic syndrome. Prevention and treatment. Moscow: Medpraktika; 2002. 182 p. Russian).
- Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L; Vasorisk group. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012;12:3.
- Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011;95(5):875–92.
- van Dijk SB, Takken T, Prinsen EC, Wittink H. Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis. Neth Heart J. 2012;20(5):208–18.
- Houben AJ, Eringa EC, Jonk AM, Serne EH, Smulders YM, Stehouwer CD. Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease. Curr Cardiovasc Risk Rep. 2012;6(1):80–90.
- Аметов АС, Камынина ЛЛ. Проблема висцерального ожирения в диабетологии (патогенетические, клинические и эпидемиологические аспекты). Эндокринология. 2012;(1):1–8. (Ametov AS, Kamynina LL. [The visceral adiposity as a diabetological problem (pathogenic, clinical and epidemiological aspects)]. Endokrinologiya. 2012;(1):1–8. Russian).
- Kuk JL, Ardern CI. Influence of age on the association between various measures of obesity and all-cause mortality. J Am Geriatr Soc. 2009;57(11):2077–84.
- Payne GA, Kohr MC, Tune JD. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol. 2012;165(3):659–69.
- Бутрова СА, Елисеева АЮ. Неалкогольная жировая болезнь печени. Ожирение и метаболизм. 2008;(2):2–7. (Butrova SA, Eliseeva AYu. [Non-alcoholic fatty liver disease]. Ozhirenie i metabolizm. 2008;(2): 2–7. Russian).
- Бессесен ДГ, Кушнер Р. Избыточный вес и ожирение. М.: Бином; 2004. 240 с. (Bessesen DH, Kushner R. Overweight and obesity. Moscow: Binom; 2004. 240 p. Russian).
- Беляков НА, Мазуров ВИ, ред. Ожирение. Руководство для врачей. СПб.: Издательский дом СПбМАПО; 2003. 520 с. (Belyakov NA, Mazurov VI, editors. Obesity. Guidelines for doctors. Saint Petersburg: Publishing House SPbMAPO; 2003. 520 p. Russian).
- Дедов ИИ, Мельниченко ГА, Фадеев ВВ. Эндокринология: Учебник. М.: Медицина; 2000. 632 с. (Dedov II, Mel'nichenko GA, Fadeev VV. Endocrinology: Textbook. Moscow: Meditsina; 2000. 632 p. Russian).
- Finegood DT. Obesity, inflammation and type II diabetes. Int J Obes Relat Metab Disord. 2003;27 Suppl 3:S4–5.
- Косыгина AB, Васюкова ОВ. Новое в патогенезе ожирения: адипокины – гормоны жировой ткани. Проблемы эндокринологии. 2009;55(1):44–50. (Kosygina AV, Vasyukova OV. [New in the pathogenesis of obesity: adipokines – adipose tissue hormones]. Problemy endokrinologii. 2009;55(1):44–50. Russian).
Supplementary files
